1. Home
  2. OMDA vs AMPH Comparison

OMDA vs AMPH Comparison

Compare OMDA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OMDA
  • AMPH
  • Stock Information
  • Founded
  • OMDA 2011
  • AMPH 1996
  • Country
  • OMDA United States
  • AMPH United States
  • Employees
  • OMDA N/A
  • AMPH N/A
  • Industry
  • OMDA Medical/Nursing Services
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • OMDA Health Care
  • AMPH Health Care
  • Exchange
  • OMDA Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • OMDA 1.2B
  • AMPH 1.1B
  • IPO Year
  • OMDA 2025
  • AMPH 2014
  • Fundamental
  • Price
  • OMDA $21.32
  • AMPH $30.50
  • Analyst Decision
  • OMDA Strong Buy
  • AMPH Buy
  • Analyst Count
  • OMDA 6
  • AMPH 5
  • Target Price
  • OMDA $25.00
  • AMPH $36.20
  • AVG Volume (30 Days)
  • OMDA 430.6K
  • AMPH 641.0K
  • Earning Date
  • OMDA 08-07-2025
  • AMPH 08-07-2025
  • Dividend Yield
  • OMDA N/A
  • AMPH N/A
  • EPS Growth
  • OMDA N/A
  • AMPH N/A
  • EPS
  • OMDA N/A
  • AMPH 2.68
  • Revenue
  • OMDA $209,827,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • OMDA $33.26
  • AMPH $1.06
  • Revenue Next Year
  • OMDA $20.16
  • AMPH $7.06
  • P/E Ratio
  • OMDA N/A
  • AMPH $11.38
  • Revenue Growth
  • OMDA 135.27
  • AMPH 1.37
  • 52 Week Low
  • OMDA $14.14
  • AMPH $20.39
  • 52 Week High
  • OMDA $28.40
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • OMDA N/A
  • AMPH 74.11
  • Support Level
  • OMDA N/A
  • AMPH $29.42
  • Resistance Level
  • OMDA N/A
  • AMPH $30.99
  • Average True Range (ATR)
  • OMDA 0.00
  • AMPH 1.31
  • MACD
  • OMDA 0.00
  • AMPH 0.51
  • Stochastic Oscillator
  • OMDA 0.00
  • AMPH 93.07

About OMDA Omada Health Inc. Common Stock

Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: